Forefront talks $100 million term loan at SOFR plus 525-550 bps

By Sara Rosenberg

New York, Dec. 8 – Forefront Dermatology (Dermatology Intermediate Holdings III Inc.) launched on Friday its non-fungible $100 million incremental first-lien term loan due April 2, 2029 with price talk of SOFR plus 525 basis points to 550 bps with a 0.5% floor and an original issue discount of 97 to 98, according to a market source.

The incremental term loan has 101 soft call protection for six months and is co-terminous with the company’s existing first-lien term loan.

UBS Investment Bank is the arranger on the deal.

Commitments are due at noon ET on Wednesday, the source added.

Proceeds will be used to repay revolving credit facility drawings and to fund acquisitions under letters of intent.

Partners Group is the sponsor.

Forefront Dermatology is a Manitowoc, Wis.-based dermatology physician practice.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.